[Input from a specialized nurse consultation in the management of detrusor overactivity treated with intradetrusor injections of botulinum toxin in urology department. Pilot study].
OBJECTIVE
To adapt in daily practice, in a urology department, recommendations for good clinical practice for follow-up of neurological patients with neurogenic detrusor overactivity treated with injections of botulinum toxin type A by involving a referent nurse in neuro-urology.


METHODS
A nurse consultation in neuro-urology has been created in June 2007 to intervene at each follow-up consultation at D0, D8, D45, then by phone until reappearance of functional signs to organize a new injection of botulinum toxin. This pilot study evaluated the faisability, the input on clinical workload, and the benefit on relationship between the patient and the caregiver.


RESULTS
An improvement of the quality of care has been given to the patient since first contact to follow-up. The number of neurological patient transfers and waiting time between the recurrence of functional signs and new therapeutic care were reduced. The number of medical consultations has been reduced saving time to redistribute on other activities. Knowledge improvement and privileged relationship with the patient and the doctor were reported by the referent nurse.


CONCLUSIONS
The participation of a referent nurse in neuro-urology has improved the quality of care of these patients from first contact to follow-up and has allowed adaptation of the recommendations in the practice of caring of an urology department.
Le Gal
S
S
Service d'urologie, CHU Charles-Nicolle-Rouen, 1, rue Germont, 76031 Rouen cedex, France. sophie.legal@netcourrier.com
Safsaf
A
A
Galliot
I
I
Catovic
B
B
Grise
P
P
D000283:Administration, Intravesical; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D006801:Humans; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D009733:Nursing Diagnosis; D010865:Pilot Projects; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000451:nursing*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A